Olema Pharmaceuticals, Inc. (OLMA)

NASDAQ: OLMA · IEX Real-Time Price · USD
4.02
+0.24 (6.22%)
Aug 19, 2022 3:59 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018
Selling, General & Admin
20.397.820.40.39
Research & Development
51.113.73.921.69
Operating Expenses
71.4921.534.322.08
Operating Income
-71.49-21.53-4.32-2.08
Interest Expense / Income
00.6500.03
Other Expense / Income
-0.4-0.06-0.010.09
Pretax Income
-71.1-22.12-4.32-2.2
Net Income
-71.1-22.12-4.32-2.2
Preferred Dividends
01.8700
Net Income Common
-71.1-23.99-4.32-2.2
Shares Outstanding (Basic)
40733
Shares Outstanding (Diluted)
40733
Shares Change
462.91%170.75%2.80%-
EPS (Basic)
-1.80-3.42-1.66-0.87
EPS (Diluted)
-1.80-3.42-1.66-0.87
Free Cash Flow Per Share
-1.32-2.84-1.19-0.86
EBITDA
-69.71-21.46-4.31-2.16
Depreciation & Amortization
1.390.010.010.01
EBIT
-71.1-21.47-4.32-2.17
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).